QT Imaging Secures $24M+ Deal to Expand Breast Cancer Screening in the UAE with Novel Acoustic Technology
Table of Contents
A new partnership promises to reshape breast cancer screening in the United Arab Emirates, leveraging cutting-edge acoustic imaging technology from QT Imaging. The company has signed an exclusive distribution agreement with Al Naghi Medical (NMC) to bring its QTI Breast Acoustic CT scanners and QTI Cloud Platform to the region.
Revolutionizing Breast Health with 3D Imaging
QT Imaging’s QTI scanner, already cleared by the US Food and Drug Governance (FDA), offers a complete, three-dimensional view of breast anatomy. Unlike conventional methods, this technology eliminates the need for contrast administration, breast compression, and exposure to ionizing radiation, potentially making screening more accessible and agreeable for patients.
The QTI Cloud Platform further enhances these capabilities by utilizing a tiered software-as-a-service (SaaS) delivery model to advance breast health through imaging intelligence and biomarkers. This platform is designed to deliver tools like automated findings classification and computer-aided diagnosis to connected systems,streamlining the diagnostic process.
Significant Order volume Signals Strong market Confidence
The distribution agreement with NMC includes a firm commitment to minimum order quantities.Initial orders will begin with seven scanners in the second quarter of 2026, increasing to 16 in 2027 and 20 in 2028. The overall agreement encompasses a minimum of 43 scanners, with projected revenue exceeding $24 million.
This expansion comes at a critical time, as breast cancer prevalence has been steadily increasing in the UAE. “We are excited to gain access to this significant market by partnering for the distribution of our technology with NMC, one of the leading medical device distributors in the UAE,” stated QT Imaging CEO Dr.Raluca Dinu. “By making breast imaging accurate, comfortable, and stress-free, we believe that our QTI breast Acoustic CT scanner can definitely help change the current breast cancer screening paradigm in the UAE, promoting earlier detection and improved prognoses.”
Potential Alternative for Dense Breast Screening
Recent data, announced by QT Imaging in April 2024, suggests the Breast acoustic CT scan could serve as a viable alternative to mammography, particularly for women with dense breasts or those who are younger. This finding could significantly broaden the reach of effective breast cancer screening, addressing limitations of existing technologies.
the partnership with NMC represents a major step forward for QT Imaging, positioning its innovative technology to address a growing healthcare need in the UAE and potentially transform the landscape of breast cancer detection and treatment.
Why: QT Imaging partnered with Al Naghi Medical (NMC) to expand access to its QTI Breast Acoustic CT scanners and QTI Cloud Platform in the UAE, driven by increasing breast cancer prevalence and the need for more comfortable and accessible screening options.
Who: QT Imaging, a medical technology company, and Al Naghi Medical (NMC), a leading medical device distributor in the UAE, are the key players. Dr. Raluca Dinu,CEO of QT Imaging,also provided a statement.
What: QT Imaging secured an exclusive distribution agreement with NMC valued at over $24 million,involving a minimum order of 43 scanners delivered between 2026 and 2028. The agreement aims to introduce a novel, radiation-free breast cancer screening technology to the UAE market.
How did it end?: The agreement is currently active, with initial scanner deliveries scheduled for the second quarter of 2026. The partnership is expected to continue through 2028, with ongoing scanner deliveries and the implementation of the QTI Cloud Platform. The ultimate outcome will be measured by the impact on breast cancer detection rates and patient comfort in the UAE.
